Showing 1 - 10 of 223
  • 11 July, 2018 - 11:21
    SBRI Healthcare competition call
    SBRI Healthcare competition call 
    SBRI Healthcare is inviting companies to bid for funding to develop solutions for specific health needs. The focus areas are Improving Outcomes in Musculoskeletal Disorders and Dentistry, Oral Health and Oral Cancers.
    The deadline for applications is 22 August 2018 (12 noon). For further information and any questions, call SBRI Healthcare on 01223 928040 or email:

    Briefing event
    SBRI Healthcare are holding a briefing event in London on 19 July 2018. The event will cover competition specification, the application process, support available to companies and the opportunity to present questions to the panel. Find out more on the SBRI Healthcare website.
  • 30 May, 2018 - 08:50
    We’d like to stay in touch
    We’d like to stay in touch

    The purpose of the West Midlands Academic Health Science Network (WMAHSN) is to improve health and promote economic growth through the adoption of innovation that meets the defined needs of the West Midlands health economy.  

    To achieve this we bring together collaborations between education, training, research, informatics, healthcare providers, patients, carers and others in order to deliver the intended outcomes.  As you are a user of Meridian, we hold some of your personal data in order to be able to include you in such work.  

    Our communications to you are therefore a part of achieving our objectives and we endeavour to be honest and transparent in how we do this.  You may have read or heard that the General Data Protection Regulations (GDPR) on how such data are used and managed has come into force from 25th May 2018, alongside our Data Protection Act 2018. These strengthen existing laws and further protect your rights regarding how organisations gather, store and process your personal information and how you can access, restrict further processing, rectify any errors or delete it.  

    Our position on GDPR

    We have taken advice from our host organisation, University Hospitals Birmingham NHS Foundation Trust, and we have extensively reviewed how we collect, store and process individuals’ data.  We have issued a privacy policy detailing how we do this and you can access that here.  

    As we are commissioned by the NHS and the Office for Life Sciences to carry out our task in the public interest of improving health and creating economic growth, you will continue receiving our communications.  However, if you would prefer to unsubscribe from future communications now or at any time in the future, please email your request to  We will then ensure you are removed from the mailing list and your data will be deleted.  

    If you require any more information on how we use individuals’ data or on any other aspect of WMAHSN and GDPR, please email and we will be pleased to oblige.  
  • 16 May, 2018 - 08:54
    NIHR Funding Opportunities
    NIHR: Research for Patient Benefit - Social care call

    Details: The NIHR is pleased to announce that the Research for Patient Benefit Social Care Competition has now launched. This initiative seeks to fund high quality research ideas which come from the front line of social care, and to support partnerships between social care researchers and practitioners. This applies across a wide spectrum of topic areas for research, which has the potential to improve adult social care practice. It will be open to universities, local authorities and NHS bodies or other providers of NHS services in England with individual project awards up to £350,000 available.

    Deadline for proposals: 1pm on 4th July 2018.
    Find out more here<>.

    Stroke Association: Priority Programme Awards

    Details: These awards are aimed at addressing critical gaps in stroke research evidence. The 2018 round of the Priority Programme Awards is on the psychological consequences of stroke. Priority Programme Awards offer up to £410,000 over 3 to 5 years.

    Deadline for proposals: 5pm on 13th June 2018.
    Find out more here<>.

    MRC: The aetiology of self-harm and eating disorders

    Details: The Medical Research Foundation and MRC will make available up to £2.5 million for new high-quality, internationally competitive research to investigate the aetiology and underpinning mechanisms of self-harm or eating disorders, including the underlying bio-psycho-social mechanistic and environmental drivers, in children, adolescents and young adults (up to 25 years).

    Deadline for proposals: 4pm on 26th July 2018.
    Find out more here<>.

    MRC: Methodology research programme: June 2018

    Details: The MRC/NIHR Methodology Research Programme (MRP) is co-funded by the MRC and the NIHR. For the purposes of obtaining funding from MRP, methodology research must include at least one of the following:
    • Research primarily targeting underpinning methodologies, to create generalizable learning. Research must extend beyond a single case-study or application.
    • Methods in research', the development of methods for their implementation in research standards, with the aim of improving quality and consistency in practice, for example consensus statements.
    • Research framed within a pathways to disseminate the developed methodology, or associated learning, such as to maximise implementation and adoption. This can be comparative to test and evaluate methodology or translational to create step changes in utility or uptake.
    • Research that is led by the methodological needs of a breadth of researchers, where research outputs are designed to maximise the informative value and utility across this breadth.
    Deadline for proposals: 4pm on 20th June 2018.
    Find out more here<>.

    MRC: UK-São Paulo/Brazil: Neglected Infectious Diseases Joint Centre Partnerships

    Details: The MRC and the São Paulo Research Foundation are pleased to invite proposals to the UK-São Paulo/Brazil Neglected Infectious Diseases Joint Centre Partnerships Initiative under the umbrella of the Newton Fund. This initiative will provide funding for high quality collaborative Joint Centre Partnerships focused on addressing Neglected Infectious Diseases in Brazil.

    MRC will make up to £3.5m funding available for this initiative, with equivalent effort matched by FAPESP. The funders wish to support proposals with the aim of:
    • existing partnerships and developing new partnerships between the UK and São Paulo-Brazil in the area of Neglected Infectious Diseases
    • supporting collaborative research
    • supporting the mobility and exchange of UK and Brazilian researchers to enhance links between researchers in both countries
    • strengthening the strategic relationship between the UK and Brazil.
    Deadline for proposals: 4pm on 19th July 2018
    Find out more here<>.
  • 10 May, 2018 - 13:27
    Artificial Intelligence in Health and Social Care in England Mapping and Thought Leadership Questionnaire
    The Academic Health Science Network (AHSN) Artificial Intelligence Initiative seeks your input to create the ‘go to’ Directory of AI in Health and Social Care in England.

    By taking part in this short survey you will help us to showcase how AI is being used in healthcare and preventative health, and highlight barriers and enablers to its effective development. The project’s aim is to develop and drive innovation and adoption of AI technology throughout health and social care, improving care at less cost and promoting healthy lifestyles.

    As part of this work, we are particularly keen to hear of AI case studies that could have a short-term impact, especially in the area of diagnostics.  To read more about the benefits of taking part and to access the survey please click here.
  • 27 April, 2018 - 09:15
    Would you like to learn more about the Innovation Loans Open Competition?
    Innovate UK is working to broaden the range of innovation finance support available to businesses, so they can access funding at all stages of innovation. 

    Innovation loans are for UK small or medium-sized enterprises (SMEs) that want to scale up and grow through innovation, developing new or improved products, processes or services. They can be used for late-stage research and development (R&D) projects, which have not yet reached the point of commercialisation.

    Join us at a briefing event near you or watch online
    The briefing events are designed to provide vital information to enable businesses to decide if an innovation loan is appropriate for them and, if so, to develop a clear and compelling application that shows that they have an innovative project and are suitable for a loan.
    The competition launch event, with a live and recorded webinar, will take place in London on Monday 30th April 2018. Further briefing events will be held across the UK:
    Further information

    Further information on the April 2018 Open Competition for Innovation Loans can be found on the Innovate UK competition page here
    The deadline for registration for the competition is 12:00 on 6 June 2018 and the application deadline is 12:00 on 13 June 2018.
  • 9 April, 2018 - 09:15
    Open Accelerator (OA) is the international fast track acceleration program dedicated to projects in life sciences, with a specific focus on Central Nervous System (CNS) and Respiratory diseases (including rare diseases in those areas).

    The Call for Projects is open from today till the 10th of June 2018. 

    OA is scouting for projects and startups in the following technological areas:
    • BIG DATA
    The Acceleration Program starting in September will provide intensive training, support from international experts, dedicated mentorship, business services from Deloitte, legal advice from Bird&Bird and technical support from Zambon.

    Upon completion of the Acceleration Program, the most promising projects selected by a distinguished jury will have the opportunity to:
    • Co-develop their projects with Zambon as strategic Partner;
    • Get milestones-based Seed Investment up to €100.000;
    • Use Labs and Office Spaces for free in OpenZone scientific campus;
    • Connect with a high profile network of scientific experts and business leaders;
    • Receive Advisory services from Deloitte and legal support from Bird & Bird.
    Open Accelerator is created by Zcube, research venture of Zambon Group, and is located in Bresso, Milan at the OpenZone scientific campus where 22 successful Life Sciences companies reside.

    For more information visit the web site or contact us at
  • 21 March, 2018 - 14:06
    WMAHSN/Ideas UK Networking Event: Challenge Based Innovation
    This event is aimed at anyone working in the areas of ideas management, innovation or who has a general interest in understanding how to formulate challenges to inform future service or organisational development.  

    This event is organised in partnership with the West Midlands Academic Health Science Network (WMAHSN) and Ideas UK and will provide attendees the opportunity to find out and discuss the following: 
    • defining the need/challenge
    • engaging people in the definition 
    • making idea identification relevant 
    • getting buy in 
    • communicating the challenge
    • skills needed

    Please note this event is not specifically open to organisaitons working in the healthcare sector.  To book your place please click here.
  • 13 March, 2018 - 13:24
    Med-Tech: Innovations and Opportunities Evening
    You are cordially invited to attend ‘Med-Tech: Innovations and Opportunities Evening’ organised by Warwick Medical School on 10 April.

    This is the first in a series of networking events aimed at creating a forum to share ideas, strengthen existing interactions and develop new partnerships.

    We will showcase the cutting-edge expertise and technologies that are available at Warwick and explore joint funding opportunities.
    This free event will start with a keynote address by Professor Malcolm Skingle CBE, Director of Academic Liaison at GSK, entitled ‘Leveraging Science & Funding to underpin R&D’. Dinner will follow, providing a networking opportunity and further short presentations will showcase funding opportunities, available technology platforms and how to access local expertise in both the University and the NHS.
    This event is aimed at companies with an interest in medical technologies, as well as those supporting the sector such as product design/development consultancies, and financial and legal organisations.
    A limited number of spaces are available for this free event so we recommend early registration.

    Register here

    We look forward to seeing you at University of Warwick on 10 April.

    Professor Lawrence Young
    Pro-Dean for External Affairs, Warwick Medical School
    University of Warwick
  • 12 March, 2018 - 11:47
    Aseptika and Zenzium Win Innovate UK funding to build Artificial Intelligence (AI) into Apps and Medical Wearables
    Aseptika and Zenzium Win Innovate UK funding to build Artificial Intelligence (AI) into Apps and Medical Wearables: supporting patients with respiratory disease

    Monday 12th March 2018, St Ives, Cambridgeshire: Aseptika and Zenzium, Ltd., have been awarded a grant from the UK’s innovation agency to develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence (AI) will automatically analyse and learn from data generated by the patient at home, using easy-to-use medical monitors and wearables, which connect to Aseptika’s Activ8rlives App.

    “You have a 75% chance of becoming ill in 7 days. You need to ask for help and start taking your Rescue Pack.”

    This will be the level of expertise available to patients that self-care at home that suffer from severe respiratory disease when AI is combined with the latest connected home-use medical monitors and wearables to avoid having to go to hospital.

    The Winter of 2017-2018 will be remembered as the time the NHS treated a record number of patients in its A&E departments. Planning for this was extensive, but demand outstripped supply and NHS frontline staff worked around the clock, prompting new calls to find solutions for the challenges in providing health and social care for an ageing population.

    The challenge for many patients that have long-term health conditions is knowing when to act and to act sooner. Being able to tell the difference between a “bad day” due to the cold weather and the start of life-threatening exacerbation can be a problem for many patients. 

    Acting earlier means that an exacerbation can be controlled with steroids and/or antibiotics in “rescue packs” that patients are issued with to keep at home for emergencies. All too often, patients start using their rescue packs too late and their health deteriorates quickly. Many patients admitted as an emergency this winter, were suffering from respiratory conditions set-off by the winter flu.

    Aseptika and Zenzium will work together to create a system to automatically warn when the patients health is declining. Looking at anonymised information gathered from previous clinical trials showed that many patients do not treat exacerbations and may not even be aware that they are having them. Some perhaps delay treatment hoping that things will get better by themselves. The inflammation of lung tissue during an exacerbation leads to irreversible damage. Over time and after repeated cycles, patients develop shortness of breath and even more opportunities for infections to take hold, in a downward spiral.

    With funding from Innovate UK, the two companies will develop a series of mathematical algorithms, which could be used to prewarn patients of the start of an exacerbation process and to give a risk score for predicted severity to urge earlier action. These patterns are different for each patient but are often repeated. These will be automatically analysed to give a personal detection score that will be continually updated as it learns about each patient and contributes this knowledge to evolve its understanding of these conditions.

    The Companies will introduce this Smart LungHealth system in the form of the Cloud-connecting Activ8rlives4 App and will also embed the AI alerting system into Aseptika’s future wearable medical monitor called the BuddyWOTCH, currently in development.
  • 12 March, 2018 - 08:50
    Differentiated Vs. Incremental Innovation – Are you Focusing on your Customers?
    We often talk about incremental innovation or radical innovation, but what about the spectrum that lies between and are you really focussing on your customers?
    Join ideasUK and Wazoku on Thursday 22 March 9:00 GMT/13:00 GST for a 30 minute online webinar to:
    • Get familiar with the innovation spectrum and the different types of innovation
    • Find out which part of the spectrum your organisation falls into
    • Define differentiated or customer-centric innovation
    • Learn about the advantages of incremental innovation
    • Find out how moving up the innovation spectrum affects the organisational culture 
    Zena Cox, Operations Director, ideasUK
    Rosemarie Diegnan, Chief Strategy & product Officer, Wazoku
    Milena Veneva, Partner Marketing Manager, Wazoku
    To register, click the following link: